PP07 Predictors of Weight Gain and Disease

Program: Abstracts - Orals, Poster Previews, and Posters
Poster Session
Obesity, Adipocyte Biology and Appetite-Basic
Friday, April 1, 2016: 11:30 AM-11:45 AM
Room 160 (BCEC)
Chairs:
Marie E. McDonnell, MD, Brigham and Women's Hospital, Boston, MA and Erin C Hanlon, PhD, Univ of Chicago, Chicago, IL

Nothing to Disclose: MEM, ECH Disclosure Not Provided: CMA
Ana Elena Espinosa De Ycaza, Division of Endocrinology, Mayo Clinic, Rochester, MN, Diane Donegan, MB BCh BAO, MRCPI, Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, MN and Michael Dennis Jensen, MD, Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, MN
Poster Board Number: FRI 604
Luiz Guilhemme Grossi Porto, BPE, MSc, PhD1, Maria N Korre, MPH2, Steven Moffatt, MD3 and Stefanos N Kales, MD, MPH, FACP, FACOEM2, (1)Environmental & Occupational Medicine & Epidemiology Program - Department of Environmental Health, Harvard T. H. Chan School of Public Health and University of Brasilia Faculty of Physical Education, Brazil, Boston, MA
(2)Environmental and Occupational Medicine and Epidemiology Program (EOME) - Department of Environmental Health, Harvard T. H. Chan School of Public Health and Cambridge Health Alliance, Harvard Medical School, Boston, MA
(3)Public Safety Medical, Indianapolis, IN
Poster Board Number: FRI 605
Corey J Lager, MD1, Nazanene H Esfandiari, MD2, Andrew T Kraftson, MD2, Angela R Subauste, MD3, Amy L Lockwood, RD2, Darlene Bellers, MS, RDN4, Morton B Brown, Ph.D.5, Oliver A Varban, MD4 and Elif Arioglu Oral, MD2, (1)Internal Medicine, Univ of Michigan, Ann Arbor, MI
(2)Dept Int Med/Endo Metab & Diab, Univ of Michigan, Ann Arbor, MI
(3)Department of Medicine, Division of Endocrinology, University of Mississippi Medical Center, Jackson, MS
(4)Dept of General Surgery, Univ of Michigan, Ann Arbor, MI
(5)School of Public Health, Univ of Michigan, Ann Arbor, MI
Poster Board Number: FRI 637
Olivia M. Farr, PhD1, Jagriti Upadhyay, MD2, Anna Gavrieli, PhD3, Hannah Mathew3, Maria T Vamvini, MD4, Michelle Camp3, Harper Kaye3, Nikolaos Spyrou3, Anastasia Koniaris3, Holly Kilim3, Alexandra Srnka3, Alexandra Migdal, MD5 and Christos S. Mantzoros, MD, DSc, PhD6, (1)Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
(2)Harvard Medical School/ Beth Israel Deaconess Medical Center, Jamaica Plain, MA
(3)Harvard Medical School/ Beth Israel Deaconess Medical Center
(4)Internal Medicine, Mount Auburn Hospital, Cambridge, MA
(5)Endocrinology, Beth Israel Deaconess Medical Center, Boston, MA
(6)Endocrinology, BIDMC, Harvard, Boston, MA
Poster Board Number: FRI 600

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire